OverviewThe American Academy of CME, Inc. (Academy) is a not-for-profit educational foundation focused on providing high-quality, certified continuing education activities that improve the competence of healthcare professionals and change their behavior to positively impact patient care. The Academy, along with the associations and medical education companies with which it partners, have developed educational activities for physicians specialists and primary care), nurses, pharmacists, registered dietitians, transplant coordinators, and social workers. The Academy and its partners have extensive experience in the creation and execution of educational activities across multiple live and enduring formats for varied and diverse health care audiences. Our team includes both clinical specialists and professionals qualified in the practice of adult education, including development of gap analyses and instructional design, content development, meeting planning and execution, and outcomes measurement. |
Ace the Case: Multiple Myeloma Presentation in the Community Setting
Effective treatment of multiple myeloma (MM) requires significant clinical coordination, as MM treatment plans are highly individualized. Treatment is influenced by many factors, including patient demographics, biomarkers, level of disease progression, response to previous treatments, individual treatment goals, and the preferred treatment paradigms of individual practitioners.
This education...
|
|
Ace the Case: Newly Diagnosed AML: Can Molecular Markers Direct Treatment?
Knowledge of the key management issues for patients with AML is critical. Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and potential adverse events associated with treatment. Early identification and intervention are critical to reduce the potential for serious adverse events and complications.
|
|
Ace the Case: Older Adult with Therapy-Related AML
Knowledge of the key management issues for patients with AML is critical Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and potential adverse events associated with treatment. Early identification and intervention are critical to reduce the potential for serious adverse events and complications.
|
|
Ace the Case: Pulmonary Arterial Hypertension (PAH) Presentation and Evaluation by Pulmonary Specialist
Pulmonary hypertension (PH) comprises a heterogeneous group of disorders that share a common clinical feature - mean pulmonary artery pressure greater than 20 mm Hg. PH may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases. Early diagnosis is critical to ensure patients are eligible for the widest spectrum of treatment options an...
|
|
Ace the Case: Pulmonary Arterial Hypertension (PAH) Presentations in the Primary Care Setting
Pulmonary hypertension (PH) comprises a heterogeneous group of disorders that share a common clinical feature - mean pulmonary artery pressure greater than 20 mm Hg. PH may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases. Early diagnosis is critical to ensure patients are eligible for the widest spectrum of treatment options an...
|
|
Ace the Case: Pulmonary Arterial Hypertension (PAH) Treatment Decisions and Therapy Initiation by Pulmonary Hypertension Specialist
Pulmonary hypertension (PH) comprises a heterogeneous group of disorders that share a common clinical feature - mean pulmonary artery pressure greater than 20 mm Hg. PH may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases. Early diagnosis is critical to ensure patients are eligible for the widest spectrum of treatment options an...
|
|
Ace the Case: R/R MM After 4 Lines of Therapy: What are the options?
Effective treatment of multiple myeloma (MM) requires significant clinical coordination, as MM treatment plans are highly individualized. Treatment is influenced by many factors, including patient demographics, biomarkers, level of disease progression, response to previous treatments, individual treatment goals, and the preferred treatment paradigms of individual practitioners.
This education...
|
|
Ace the Case: Supporting Older Adults with AML
Knowledge of the key management issues for patients with AML is critical. Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and potential adverse events associated with treatment. Early identification and intervention are critical to reduce the potential for serious adverse events and complications.
|
|
Ace the Case: Treating First Multiple Myeloma Relapse in the Community Setting
Effective treatment of multiple myeloma (MM) requires significant clinical coordination, as MM treatment plans are highly individualized. Treatment is influenced by many factors, including patient demographics, biomarkers, level of disease progression, response to previous treatments, individual treatment goals, and the preferred treatment paradigms of individual practitioners.
This education...
|
|
Asthma Evaluation and Management to Optimize Patient Outcomes
Program Overview
Patients with asthma are likely to present first in the primary care setting, thus affording primary care team members an opportunity to reduce the number of patients who are misdiagnosed and to support the correct use of inhalers and adherence. Asthma management is evolving, and evidence-based guidelines and interdisciplinary models of care can help individualize treatment and...
|
|
Best of ACTHIV® 2023: Approaches to ART Optimization in the Virally Suppressed Patient
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module will provide guidance on when to consider an ART change in a virally suppressed person, and the use of 2-drug regimens.
Assess when to consider ART change in a virally suppressed person
Appraise when a 2-drug regimen is appropriate,...
|
|
Best of ACTHIV® 2023: Diabetes Management and Weight Loss in People with HIV
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module discusses how to determine an appropriate diabetes medication regimen for patients with HIV and how to select an appropriate weight loss medication option for patients with HIV.
Determine an appropriate diabetes medication regimen fo...
|
|
Best of ACTHIV® 2023: Hepatitis B in People with HIV
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module will examine best practices for evaluating people with HBV and HIV and will review the risk of liver complications associated with HBV viremia in people with HIV.
Describe best practices for evaluating people with HBV and HIV
Apprai...
|
|
Best of ACTHIV® 2023: HIV 101: Pathogenesis
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this activity will describe HIV infection and viral dynamics, define how viral dynamics impact management of antiretroviral therapy, and describe current progress in area of HIV cure/remission.
Describe HIV infection and viral dynamics
Define h...
|
|
Best of ACTHIV® 2023: Initial ART Regimens for the Newly Diagnosed Patient with HIV
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module reviews first-line HIV regimens for newly-diagnosed patients with HIV including side effects, discusses rapid ART initiation in newly-diagnosed patients, explores adherence challenges on oral ART and use of long-acting ART, and provides...
|
|
Best of ACTHIV® 2023: Syphilis and Its Management Among Persons with HIV: Case-Based Approaches
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module will utilize cases to illustrate when syphilis titers should be performed to trend response to treatment, the interpretation of syphilis titers, how to identify when there has been a serologic treatment failure and what to do about it, ...
|
|
Case Studies in HIV Prevention Among Communities at High Risk for HIV
Case Studies in HIV Prevention Among Communities at High Risk for HIV
Release Date: December 23, 2022
Expiration Date: December 23, 2023
Estimated Time to Complete: 1.0 hour
VIEW ACTIVITY
Support for this activity has been made possible through educational grants from Gilead Sciences, Merck, Theratechnologies, and ViiV Healthcare.
Educational Need:
Access to HIV prevention, inclu...
|
|
Case Studies in HIV Prevention and Treatment of Persons Who Use Drugs
Educational Need:
Prevention of HIV in individuals with substance use disorder (SUD) is vitally important from a public health perspective. People with SUD are significantly more vulnerable to contracting HIV, attributable to behaviors such as sharing needles and injection equipment, engaging in condomless sex, and impaired judgement. Furthermore, substance use can negatively affect medication...
|
|
Case Studies in HIV Resistance Testing and Treatment " Experienced Patients
Educational Need:
Through a series of patient cases, participants will explore the complexities of managing HIV infection in patients who have been treated with multiple different HIV regimens. Participants will engage in real-life case studies that will provide valuable insight into the intricacies of HIV treatment and resistance testing. Our faculty educators will discuss commonly encountere...
|
|
Case Studies in Identifying and Addressing Intimate Partner Violence among People with HIV
The prevalence of intimate partner violence (IPV) is high among people with HIV (PWH). PWH who report IPV are more likely to have poor HIV-related health outcomes (i.e., limited retention in care and poor adherence to antiretroviral therapy), sexually transmitted infections, mental health disorders, and poor overall physical health. HIV care visits are an opportunity to assess for and address IP...
|
|
Combating the Stigma of Opioid Addiction
This webinar will address the stigma of addiction and how that effects people with substance use disorders. Experts will discuss the ways in which stigma serves as a barrier to effective prevention, treatment and recovery and highlight resources available to help overcome it and begin to break down this stigma in society.
|
|
Disparities in Ovarian Cancer: Increasing Awareness to Improve Risk Assessment and Outcomes
Ovarian cancer is the most common cause of cancer death in women with gynecologic malignancy and the fifth leading cause of cancer death in the US. Although the incidence of ovarian cancer is higher among White women than Black women, studies have identified disparities in assessment, care and outcomes seen among Black women with ovarian cancer. It has been shown that outcomes in clinical oncolo...
|
|
GOCCNJ Summit: Improving Quality Care for People with Serious Illness
Did you know that New Jersey patients near the end of life are treated with more aggressive medical care than patients in any other state in the U.S.?
This high-intensity, high-cost care is often unwanted and burdensome to both patients and their caregivers. Key reasons for this burdensome care are the lack of knowledge about palliative and end-of-life care services, and comfort discussing th...
|
|
Is It Safe? Safety Surveillance through the Antiretroviral Pregnancy Registry
Is It Safe? Safety Surveillance through the Antiretroviral Pregnancy Registry
Release Date: June 2, 2023
Expiration Date: June 2, 2024
Estimated Time to Complete: 1.25 hour
VIEW ACTIVITY
Clinical Gap and Educational Need
Antiretroviral therapy should be initiated for all persons with HIV who are pregnant regardless of CD4 count according to current guidelines. There is often min...
|
|
Metastatic Colorectal Cancer: Targeting Key Clinical Issues for Oncology Nurses
New targeted therapies for metastatic colorectal cancer have increased the need for awareness, education, and training for oncology nursing professionals to better prepare them to confidently manage and educate patients.
Upon completion of this activity, participants should be better able to:
Assess appropriate treatment options for a patient with mCRC who has failed first- and second-line...
|
|
The Role of the Clinical Pharmacist in the Management of Multiple Myeloma
Multiple myeloma (MM) is the second most common hematologic malignancy in the United States and is characterized by monoclonal proliferation of malignant plasma cells that accumulate within the bone marrow. The incidence of MM has increased in recent years, in part due to the revised definition of symptomatic MM from the International Myeloma Working Group in 2014. The National Cancer Institute ...
|